Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Purdue Pharma L.P.
October 16, 2025
Purdue Pharma L.P.
Orphan Drug Designation
FDA orphan drug designation: treatment of malignant glioma
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
